UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells Journal article
Miao, Lingchao, Zhang, Haolin, Cheong, Meng Sam, Zhong Ruting, Garcia-Oliveira, Paula, Prieto, Miguel A, Cheng, Ka-Wing, Wang, Mingfu, Cao, Hui, Nie, Shaoping, Simal-Gandara, Jesus, Cheang, Wai San, Xiao, Jianbo. Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells[J]. Food Science and Human Wellness, 2023, 12(6), 1991-2000.
Authors:  Miao, Lingchao;  Zhang, Haolin;  Cheong, Meng Sam;  Zhong Ruting;  Garcia-Oliveira, Paula; et al.
Favorite | TC[WOS]:25 TC[Scopus]:26  IF:5.6/6.8 | Submit date:2022/08/11
Apigenin  Luteolin  Baicalein  Insulin-resistant Hepg2 Cells  Signaling Pathway  Reactive Oxygen Species (Ros)  Advanced Glycation End-products (Ages)  Glycogen Synthase Kinase (Gsk-3β)  Glucose Transporter Protein 4 (Glut4)  
Apigenin alleviates diabetic endothelial dysfunction through activating AMPK/PI3K/Akt/eNOS and Nrf2/HO-1 signaling pathways Journal article
Miao, Lingchao, Cheong, Meng Sam, Zhou, Chunxiu, Farag, Mohamed, Cheang, Wai San, Xiao, Jianbo. Apigenin alleviates diabetic endothelial dysfunction through activating AMPK/PI3K/Akt/eNOS and Nrf2/HO-1 signaling pathways[J]. Food Frontiers, 2023, 4(1), 420-431.
Authors:  Miao, Lingchao;  Cheong, Meng Sam;  Zhou, Chunxiu;  Farag, Mohamed;  Cheang, Wai San; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7 | Submit date:2022/12/23
Apigenin  Diabetes Mellitus  Endothelial Dysfunction  Nitric Oxide  Asoprotection  
Current status and future perspectives on therapeutic potential of apigenin: Focus on metabolic-syndrome-dependent organ dysfunction Journal article
Alam, Waqas, Rocca, Carmine, Khan, Haroon, Hussain, Yaseen, Aschner, Michael, De Bartolo, Anna, Amodio, Nicola, Angelone, Tommaso, Cheang, Wai San. Current status and future perspectives on therapeutic potential of apigenin: Focus on metabolic-syndrome-dependent organ dysfunction[J]. Antioxidants, 2021, 10(10).
Authors:  Alam, Waqas;  Rocca, Carmine;  Khan, Haroon;  Hussain, Yaseen;  Aschner, Michael; et al.
Favorite | TC[WOS]:28 TC[Scopus]:32  IF:6.0/6.7 | Submit date:2021/12/08
Antioxidants  Apigenin  Flavonoids  Intracellular Signalling  Metabolic Syndrome